Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …

T Santo, B Clark, M Hickman, J Grebely… - JAMA …, 2021 - jamanetwork.com
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

L Sordo, G Barrio, MJ Bravo, BI Indave, L Degenhardt… - bmj, 2017 - bmj.com
Objective To compare the risk for all cause and overdose mortality in people with opioid
dependence during and after substitution treatment with methadone or buprenorphine and …

Retention of patients in opioid substitution treatment: a systematic review

AM O'Connor, G Cousins, L Durand, J Barry, F Boland - PloS one, 2020 - journals.plos.org
Background Retention in opioid substitution (OST) treatment is associated with substantial
reductions in all cause and overdose mortality. This systematic review aims to identify both …

Treatment of opioid-use disorders

MA Schuckit - New England Journal of Medicine, 2016 - Mass Medical Soc
Treatment of Opioid-Use Disorders | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis

J Ma, YP Bao, RJ Wang, MF Su, MX Liu, JQ Li… - Molecular …, 2019 - nature.com
Opioid use disorder (OUD) is associated with a high risk of premature death. Medication-
assisted treatment (MAT) is the primary treatment for opioid dependence. We …

Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study

LA Pearce, JE Min, M Piske, H Zhou, F Homayra… - Bmj, 2020 - bmj.com
Objective To compare the risk of mortality among people with opioid use disorder on and off
opioid agonist treatment (OAT) in a setting with a high prevalence of illicitly manufactured …

[HTML][HTML] Policy pathways to address provider workforce barriers to buprenorphine treatment

RL Haffajee, ASB Bohnert, PA Lagisetty - American journal of preventive …, 2018 - Elsevier
At least 2.3 million people in the US have an opioid use disorder, less than 40% of whom
receive evidence-based treatment. Buprenorphine used as part of medication-assisted …

Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel

L Kohan, S Potru, AM Barreveld, M Sprintz… - Regional Anesthesia & …, 2021 - rapm.bmj.com
Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services

N Krawczyk, R Mojtabai, EA Stuart, M Fingerhood… - …, 2020 - Wiley Online Library
Background and aims Evidence from randomized controlled trials establishes that
medication treatment with methadone and buprenorphine reduces opioid use and improves …

High mortality among patients with opioid use disorder in a large healthcare system

YI Hser, LJ Mooney, AJ Saxon, K Miotto… - Journal of addiction …, 2017 - journals.lww.com
Objectives: Elevated mortality has been observed among individuals with opioid use
disorder (OUD) treated in addiction specialty clinics or programs. Information about OUD …